Comments on: Drug eluting stents and late thrombosis http://www.journalclub.org/2004/10/31/n13 Comments on the medical literature Wed, 13 Jul 2005 13:30:08 +0000 hourly 1 http://wordpress.org/?v=3.0.1 By: Dr Ajay S chaurasia http://www.journalclub.org/2004/10/31/n13/comment-page-1#comment-1775 Dr Ajay S chaurasia Mon, 29 Nov 2004 16:20:44 +0000 http://www.journalclub.org/2004/10/31/n13#comment-1775 I feel pts should be studied for a plaque rupture prior to the stent implantation site. Besides they need to be studied for hypercoagulable states and clinical conditions associated with such states rather than assuming it to be related to drug eluting stents, when also it has converted itself into a bare metal one after completing the elution. I feel pts should be studied for a plaque rupture prior to the stent implantation site. Besides they need to be studied for hypercoagulable states and clinical conditions associated with such states rather than assuming it to be related to drug eluting stents, when also it has converted itself into a bare metal one after completing the elution.

]]> By: mjmd http://www.journalclub.org/2004/10/31/n13/comment-page-1#comment-92 mjmd Sat, 27 Nov 2004 16:33:17 +0000 http://www.journalclub.org/2004/10/31/n13#comment-92 From the same issue of the Lancet, in a comment on this article by M. Eisenberg: "What can we do to avoid late thrombosis after implantation with a drug-eluting stent? First, we should strongly reflect on the potential clinical consequences before we insert such a stent. Will the patient need a subsequent surgical procedure necessitating the interruption of antiplatelet therapy? If so, a drug-eluting stent might not be the best choice. Will the patient be compliant with prolonged antiplatelet therapy? If not, a bare-metal stent might be preferable." From the same issue of the Lancet, in a comment on this article by M. Eisenberg:

“What can we do to avoid late thrombosis after implantation with a drug-eluting stent? First, we should strongly reflect on the potential clinical consequences before we insert such a stent. Will the patient need a subsequent surgical procedure necessitating the interruption of antiplatelet therapy? If so, a drug-eluting stent might not be the best choice. Will the patient be compliant with prolonged antiplatelet therapy? If not, a bare-metal stent might be preferable.”

]]> By: cardioNP http://www.journalclub.org/2004/10/31/n13/comment-page-1#comment-85 cardioNP Sat, 27 Nov 2004 03:45:04 +0000 http://www.journalclub.org/2004/10/31/n13#comment-85 We recommend minimum 6 mos Plavix/ASA prior to interruption for any surgical procedure, then resumption of Plavix/ASA ASAP. In light of the above, do you think it would be wise to recommend use of bare metal stents in any patient that we know is undergoing PCI prior to needing surgery? We recommend minimum 6 mos Plavix/ASA prior to interruption for any surgical procedure, then resumption of Plavix/ASA ASAP. In light of the above, do you think it would be wise to recommend use of bare metal stents in any patient that we know is undergoing PCI prior to needing surgery?

]]>